Search Results

AWAK TECHNOLOGIES RAISES US$20+ MILLION, READYING ITS WEARABLE DIALYSIS DEVICE FOR US-BASED PIVOTAL TRIAL

AWAK Technologies (AWAK), a pioneering medical technology company focused on dialysis using regeneration technology for end-stage renal disease, today announced it has successfully raised US$20+ million in Series B funding.

September 13, 2023

·

5 min read

FDA

AWAK Technologies Announces FDA Breakthrough Device Designation for their Artificial Intelligence Enabled Kidney Disease Prediction Tool

AWAK Technologies today announced that its kidney disease progression prediction (KDPP) Artificial Intelligence (AI) model for CKD patient care has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA).

November 27, 2023

·

4 min read

Business

AWAK Technologies and Singapore General Hospital launch pre-pivotal clinical trial of wearable peritoneal dialysis device

AWAK Technologies (AWAK) and Singapore General Hospital (SGH) announce the launch of a pre-pivotal clinical trial with the enrolment of their first subject to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device.

June 19, 2023

·

5 min read

Lone Star Bio

Wenzel Spine Announces First Awake Spinal Fusion Using VariLift®-LX

Wenzel Spine, a leader in the development of innovative stand-alone spinal fusion technologies and diagnostic methods, announced today a notable achievement in the company’s history with the first awake spinal fusion procedure using the VariLift®-LX interbody implant.

July 21, 2022

·

3 min read

Pictured: Woman falling asleep at her workstation/

Drug Development

Axsome Therapeutics’ Small Molecule Clears Phase III Trial in Narcolepsy

Axsome clinched a late-stage victory for its chronic sleep disorder candidate AXS-12, which demonstrated significant improvement in cataplexy—the sudden loss of muscle tone while a person is awake—after five weeks.

March 26, 2024

·

2 min read

·

Tristan Manalac

Pharm Country

Loki Therapeutics Announces Publication in Science Translational Medicine Demonstrating Potential of AWAKE-LM-TT as a Treatment for Pancreatic Cancer

Loki Therapeutics today announced the publications of research in the journal, “Science Translational Medicine”, demonstrating the potential of AWAKE-LM-TT in the treatment of pancreatic cancer

March 28, 2022

·

4 min read

Biotech Bay

AcelRx Pharmaceuticals Announces Publication of Clinical Data on the Use of Sufentanil Sublingual Tablet during Awake Plastic Surgery Procedures

AcelRx Pharmaceuticals, Inc.today announced the publication of real-world data in patients undergoing awake plastic surgery showing a rapid recovery time and minimal side effects with the use of sufentanil sublingual tablet (SST) for pain management.

February 1, 2022

·

5 min read

Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments

Inspira™ Technologies OXY B.H.N. Ltd. announced today that Company President, Director, and co-founder, Mr. Joe Hayon, will discuss the Company’s business targets, distribution agreements and next steps in a conference call to be held at 9:00am Eastern Time on Thursday, June 20, 2024.

May 30, 2024

·

2 min read

Press Releases

BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global

November 21, 2024

·

7 min read

BioMidwest

Silq Technologies Receives Innovative Technology Contract From Vizient for ClearTract® Foley Catheter

Silq Technologies announced its ClearTract® Foley Catheter has received an Innovative Technology contract from Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company.

June 13, 2024

·

3 min read